Reaction

Factor V Inhibition reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 194 reports · 11 co-occurring drugs

As of the last recalculation, Factor V Inhibition appears in 194 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is CEFTRIAXONE (PRR 290.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ceftriaxone61290.5291.0
Ceftriaxone Sodium67285.8286.3
Phytonadione13176.1176.4
Ampicillin794.094.1
Ampicillin Sodium794.094.1
Meropenem2074.474.5
Febuxostat Tablets 40 Mg665.365.3
Febuxostat Tablets 80 Mg665.365.3
Micafungin Sodium564.965.0
Tobramycin Solution764.864.9
Tobramycin Sulfate762.962.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.